Nada Fayez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nada Fayez has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Howard E. Gendelman
University of Nebraska Medical Center
2 shared publications - Mohit Kumar
Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68106, USA
2 shared publications - Samia Akter
Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68106, USA
2 shared publications - Susmita Sil
Department of Pharmacology and Experimental Neuroscience University of Nebraska Medical Center Omaha Nebraska USA
2 shared publications
Latest Publications
- Open Access
- 10 July 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1549
Colostrum Extracellular Vesicle Isolation, Characterization, and Function
Background: Colostrum extracellular vesicles (C-EVs) are nanoscale, bioactive vesicles with therapeutic potential. The mechanisms of action include the control of cellular and tissue homeostasis. These make C-EVs a novel means to control inflammatory and cellular dysfunctions. However, a limitation for their broad use is the ease of C-EV isolation and in ensuring their stability. Methods: Standard ultracentrifugation and gradient techniques used for EV recovery were employed, which included ultracentrifugation. Exodus dual-frequency ultrasonic nanofiltration (UNF) was a comparator used to overcome standard limitations by recovering pure vesicles at high concentrations. Both systems were evaluated for their abilities to recover clinical-grade C-EVs with optimal vesicle structural integrity and intact biological functions. Results: This study affirms UNF C-EV recovery by demonstrating intact Alix, CD63, Tsg101, and Flotillin antigens. The EVs maintained an intact bilayer structure with sizes ranging from to 50–200 nm. Functional tests showed preservation of their anti-inflammatory activities by suppression of pro-inflammatory cytokines and the NLRP3 inflammasome, caspase 1, interleukin-1, and 18 and maintaining cellular homeostasis. Processing time, high yield, and functional responses controlled cellular function. Conclusions: These data support the notion that UNF C-EVs can be recovered safely, at high yields, and reproducibly for future clinical applications.
- 10 July 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1549
Open AccessColostrum Extracellular Vesicle Isolation, Characterization, and Function
Background: Colostrum extracellular vesicles (C-EVs) are nanoscale, bioactive vesicles with therapeutic potential. The mechanisms of action include the control of cellular and tissue homeostasis. These make C-EVs a novel means to control inflammatory and cellular dysfunctions. However, a limitation for their broad use is the ease of C-EV isolation and in ensuring their stability. Methods: Standard ultracentrifugation and gradient techniques used for EV recovery were employed, which included ultracentrifugation. Exodus dual-frequency ultrasonic nanofiltration (UNF) was a comparator used to overcome standard limitations by recovering pure vesicles at high concentrations. Both systems were evaluated for their abilities to recover clinical-grade C-EVs with optimal vesicle structural integrity and intact biological functions. Results: This study affirms UNF C-EV recovery by demonstrating intact Alix, CD63, Tsg101, and Flotillin antigens. The EVs maintained an intact bilayer structure with sizes ranging from to 50–200 nm. Functional tests showed preservation of their anti-inflammatory activities by suppression of pro-inflammatory cytokines and the NLRP3 inflammasome, caspase 1, interleukin-1, and 18 and maintaining cellular homeostasis. Processing time, high yield, and functional responses controlled cellular function. Conclusions: These data support the notion that UNF C-EVs can be recovered safely, at high yields, and reproducibly for future clinical applications.
- Open Access
- 10 June 2026
- Published by MDPI AG in Preprints.org
Colostrum Extracellular Vesicle Isolation, Characterization, and Function
Colostrum extracellular vesicles (C-EVs) are nanoscale, bioactive vesicles with therapeutic potential. Mechanisms of action include their control of cellular and tissue homeostasis. These make C-EVs a novel means to control inflammatory and cellular dysfunctions. However, a limitation to their broad use is the ease of C-EV isolation and stability. Standard ultracentrifugation and gradient techniques used for EV isolation are costly, cumbersome, and time-consuming. Such isolation procedures require repeated ultracentrifugation. Exodus dual-frequency ultrasonic nanofiltration (UNF) isolation system can produce pure vesicles at high concentrations. Due to the need to recover C-EVs at clinical grade at high concentrations while preserving vesicle structural integrity and broad biological functions. Large-scale recovery is preserved within hours. We now affirm UNF C-EV purity by the presence of Alix, CD63, Tsg101, and Flotillin antigens. EVs’ sizes were from 50-200 nm, maintaining intact bilayer structures. Functional tests showed preservation of the vesicles’ anti-inflammatory activities with suppression of pro-inflammatory cytokines and the NLRP3 inflammasome, caspase 1, interleukin-1, and 18. These were maintained at baseline levels, sustaining cellular homeostasis. Processing time, high yields, and functional responses served to sustain cellular homeostasis. These data support that UNF-isolated C-EVs were recovered safely at high-yields and reproducibly for future clinical applications.
- 10 June 2026
- Published by MDPI AG in Preprints.org
Open AccessColostrum Extracellular Vesicle Isolation, Characterization, and Function
Colostrum extracellular vesicles (C-EVs) are nanoscale, bioactive vesicles with therapeutic potential. Mechanisms of action include their control of cellular and tissue homeostasis. These make C-EVs a novel means to control inflammatory and cellular dysfunctions. However, a limitation to their broad use is the ease of C-EV isolation and stability. Standard ultracentrifugation and gradient techniques used for EV isolation are costly, cumbersome, and time-consuming. Such isolation procedures require repeated ultracentrifugation. Exodus dual-frequency ultrasonic nanofiltration (UNF) isolation system can produce pure vesicles at high concentrations. Due to the need to recover C-EVs at clinical grade at high concentrations while preserving vesicle structural integrity and broad biological functions. Large-scale recovery is preserved within hours. We now affirm UNF C-EV purity by the presence of Alix, CD63, Tsg101, and Flotillin antigens. EVs’ sizes were from 50-200 nm, maintaining intact bilayer structures. Functional tests showed preservation of the vesicles’ anti-inflammatory activities with suppression of pro-inflammatory cytokines and the NLRP3 inflammasome, caspase 1, interleukin-1, and 18. These were maintained at baseline levels, sustaining cellular homeostasis. Processing time, high yields, and functional responses served to sustain cellular homeostasis. These data support that UNF-isolated C-EVs were recovered safely at high-yields and reproducibly for future clinical applications.